Articles
-
3 weeks ago |
optometrytimes.com | Cecelia Koetting |Jordana Joy
Cecelia Koetting, OD, FAAO, DipABO, and Madeline Yung, MD, discussed emerging treatment and patient care options for those with presbyopia during CRU 2025. In an interview with Optometry Times, Koetting highlighted the excitement and pragmatism eye care providers are approaching presbyopia, highlighting the evolving landscape of vision correction. Key points of the presentation include: Treatment landscape Koetting emphasizes that no single vision correction method works universally.
-
3 weeks ago |
optometrytimes.com | Cecelia Koetting |Jordana Joy
Neurotrophic keratitis (NK) is a critical eye condition that is often misdiagnosed and misunderstood, according to Cecelia Koetting, OD, FAAO, DipABO. In her presentation "Neurotrophic Keratitis: Multidisciplinary Approaches to Enhance Patient Outcomes," presented alongside Melissa Barnett, OD, FAAO, FSLS, FBCLA; Jennifer Li, MD; and Quan Đông Nguyễn, MD, MSc; an overview of what to look out for in diagnosing neurotrophic keratitis was given.
-
Jan 8, 2025 |
optometrytimes.com | Cecelia Koetting |Jordana Joy
January 8, 2025By EnVision Summit Cochair Cecelia Koetting, OD, FAAO, Dipl ABO, says that attendees should get ready for more discussion-based panels at this year's conference. Optometry and ophthalmology tracks will continue to collide at this year's EnVision Summit, being held in Puerto Rico from February 14 to 17, 2025. Cecelia Koetting, OD, FAAO, Dipl ABO, cochair of EnVision Summit, remarks of previous success from the 2024 conference and what is getting her excited about this year's event.
-
Nov 25, 2024 |
healio.com | Cecelia Koetting |Kate Young |Heather Biele
You've successfully added to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected].
-
Nov 22, 2024 |
optometrytimes.com | Cecelia Koetting |Jordana Joy
November 22, 2024By Cecilia Koetting, OD, FAAO, DipABO, cited data from a recent study that found that presbyopia treatment with 0.4% pilocarpine led to up to 86% of patients achieving 20/40 or better.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →